SEARCH:

News for Food and Drug Administration (FDA)

News > FDA

Listings 271 - 280 of 441:

HealthTronics Announces FDA Clearance and Launch of the New LithoDiamond ULTRA Lithotripter
HealthTronics, provider of urology services and products, announced the launch of its LithoDiamond ULTRA lithotripter providing an evolution in lithot...

Monebo Technologies Obtains FDA Clearance to Market the CardioBelt™ Wireless ECG System
Monebo Technologies, announced that the CardioBelt Electrode System is now available, following clearance by the United States Food and Drug Administr...

EtQ Announces Software for Electronic Submissions to the FDA
EtQ has released the beta version of the EtQ Reliance eMDR Submission Tool, enabling Medical Device Manufacturers to electronically submit Medical Dev...

FDA Approves SCHWARZ PHARMA's Neupro® (Rotigotine Transdermal System) For Treatment Of Early-stage Parkinson's DIsease
SCHWARZ PHARMA announced today that the U.S. Food and Drug Administration (FDA) has approved Neupro (Rotigotine Transdermal System) for the treatment ...

FDA Advises Manufacturers to Test Glycerin for Possible Contamination
The U.S. Food and Drug Administration (FDA) is warning pharmaceutical manufacturers, suppliers, drug repackers, and health professionals who compound ...

FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
astrom Biosciences, a regenerative medicine company, announced that the U.S. Food & Drug Administration (FDA) approved the Company's Investigational N...

Scientists Conclude Very Low Risk to Humans from Food Containing Melamine: FDA
There is very low risk to human health from consuming meat from hogs and chickens known to have been fed animal feed supplemented with pet food scraps...

FDA Advises Manufacturers to Test Glycerin for Possible Contamination
he U.S. Food and Drug Administration (FDA) is warning pharmaceutical manufacturers, suppliers, drug repackers, and health professionals who compound m...

FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
Aastrom Biosciences, a regenerative medicine company, announced that the U.S. Food & Drug Administration (FDA) approved the Company's Investigational ...

Genaera Corporation Initiates Human Study of Obesity Compound Trodusquemine
Genaera Corporation announced that it has begun enrolling subjects in the first human clinical study of trodusquemine (MSI-1436) under the Investigati...

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 Next

Get Free Security Resources from Symantec